Cargando…
Health Canada's use of its priority review process for new drugs: a cohort study
OBJECTIVES: Priority reviews of new drug applications are resource intensive and drugs approved through this process have a greater likelihood of acquiring a serious safety warning compared to drugs approved through the standard process. Therefore, when Health Canada uses priority reviews, it is imp...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431066/ https://www.ncbi.nlm.nih.gov/pubmed/25967989 http://dx.doi.org/10.1136/bmjopen-2014-006816 |